Informed consent in randomized quality improvement trials: a critical barrier for learning health systems

Mark J Pletcher¹, Bernard Lo², Deborah Grady³

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco2Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.
² The Greenwall Foundation, New York, New York.
³ Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.

PMID: 24615554
DOI: 10.1001/jamainternmed.2013.13297

Editorial

Informed consent in randomized quality improvement trials: a critical barrier for learning health systems

Mark J Pletcher et al. JAMA Intern Med. 2014 May.

. 2014 May;174(5):668-70.

doi: 10.1001/jamainternmed.2013.13297.

Authors

Mark J Pletcher¹, Bernard Lo², Deborah Grady³

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco2Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.
² The Greenwall Foundation, New York, New York.
³ Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.

PMID: 24615554
DOI: 10.1001/jamainternmed.2013.13297

No abstract available

PubMed Disclaimer

Comment in

Criteria for waiver of informed consent for quality improvement research.
Baker DW, Persell SD. Baker DW, et al. JAMA Intern Med. 2015 Jan;175(1):142-3. doi: 10.1001/jamainternmed.2014.6977. JAMA Intern Med. 2015. PMID: 25560946 No abstract available.
Is there more than just 1 ethical standard for clinical trials?
Enck P. Enck P. JAMA Intern Med. 2015 Jan;175(1):143-4. doi: 10.1001/jamainternmed.2014.6974. JAMA Intern Med. 2015. PMID: 25560948 No abstract available.
Criteria for waiver of informed consent for quality improvement research-reply.
Pletcher MJ, Lo B, Grady D. Pletcher MJ, et al. JAMA Intern Med. 2015 Jan;175(1):143. doi: 10.1001/jamainternmed.2014.6997. JAMA Intern Med. 2015. PMID: 25560949 No abstract available.

Comment on

Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
Fu SS, van Ryn M, Sherman SE, Burgess DJ, Noorbaloochi S, Clothier B, Taylor BC, Schlede CM, Burke RS, Joseph AM. Fu SS, et al. JAMA Intern Med. 2014 May;174(5):671-7. doi: 10.1001/jamainternmed.2014.177. JAMA Intern Med. 2014. PMID: 24615217 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

UL1 TR000004/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Informed consent in randomized quality improvement trials: a critical barrier for learning health systems

Affiliations

Informed consent in randomized quality improvement trials: a critical barrier for learning health systems

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical